Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice

Virology

Volumn 352, Issue 1, 2006, Pages 157-168

  Lukens, Michaël V ^a   Claassen, Erwin A W ^b   de Graaff, Patricia M A ^a   van Dijk, Mariska E A ^a   Hoogerhout, Peter ^c   Toebes, Mireille ^d   Schumacher, Ton N ^d   van der Most, Robbert G ^b   Kimpen, Jan L L ^a   van Bleek, Grada M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c National Vaccine Institute   (Netherlands)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

C57BL 6; CD8+ T cells; Inactivation; Respiratory syncytial virus; Tetramer

Indexed keywords

EPITOPE; HYBRID PROTEIN; MATRIX PROTEIN; NUCLEOPROTEIN; TETRAMER;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNITY; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIMARY INFECTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SPLEEN; SUPERINFECTION; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRAL PROTEINS;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 33746556955     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.04.023     Document Type: Article

References (36)

1. Alwan W.H., Kozlowska W.J., and Openshaw P.J. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179 (1994) 81-89
2. Bangham C.R., Openshaw P.J., Ball L.A., King A.M., Wertz G.W., and Askonas B.A. Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J. Immunol. 137 (1986) 3973-3977
3. Bont L., Steijn M., Van Aalderen W.M., Brus F., Th Draaisma J.M., Diemen-Steenvoorde R.A., Pekelharing-Berghuis M., and Kimpen J.L. Seasonality of long term wheezing following respiratory syncytial virus lower respiratory tract infection. Thorax 59 (2004) 512-516
4. + T-cell memory in the respiratory tract. Nat. Med. 8 (2002) 54-60
5. Chang J., Srikiatkhachorn A., and Braciale T.J. Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection. J. Immunol. 8 (2001) 4254-4260
6. Chin J., Magoffin R.L., Shearer L.A., Schieble J.H., and Lennette E.H. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am. J. Epidemiol. 89 (1969) 449-463
7. Claassen E.A., van der Kant P.A., Rychnavska Z.S., van Bleek G.M., Easton A.J., and van der Most R.G. Activation and inactivation of antiviral CD8 T cell responses during murine Pneumovirus infection. J. Immunol. 175 (2005) 6597-6604
8. + T cells. J. Virol. 66 (1992) 7444-7451
9. + T cell immunodominance in primary and secondary influenza virus infections. J. Exp. Med. 198 (2003) 399-410
10. de Graaff P.M., de Jong E.C., van Capel T.M., van Dijk M.E., Roholl P.J., Boes J., Luytjes W., Kimpen J.L., and van Bleek G.M. Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells. J. Immunol. 175 (2005) 5904-5911
11. + T cell activation reflects altered T cell effector function. J. Immunol. 175 (2005) 1507-1515
12. Falsey A.R., Hennessey P.A., Formica M.A., Cox C., and Walsh E.E. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 352 (2005) 1749-1759
13. Gold M.C., Munks M.W., Wagner M., McMahon C.W., Kelly A., Kavanagh D.G., Slifka M.K., Koszinowski U.H., Raulet D.H., and Hill A.B. Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response. J. Immunol. 172 (2004) 6944-6953
14. + T cells following paramyxovirus infection of the respiratory tract. J. Virol. 79 (2005) 3339-3349
15. Guinazu N., Pellegrini A., Giordanengo L., Aoki M.P., Rivarola H.W., Cano R., Rodrigues M.M., and Gea S. Immune response to a major Trypanosoma cruzi antigen, cruzipain, is differentially modulated in C57BL/6 and BALB/c mice. Microbes Infect. 6 (2004) 1250-1258
16. Haanen J.B., Toebes M., Cordaro T.A., Wolkers M.C., Kruisbeek A.M., and Schumacher T.N. Systemic T cell expansion during localized viral infection. Eur. J. Immunol. 29 (1999) 1168-1174
17. Hall C.B., Walsh E.E., Long C.E., and Schnabel K.C. Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 163 (1991) 693-698
18. + T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27 (1997) 3341-3349
19. Hussell T., Georgiou A., Sparer T.E., Matthews S., Pala P., and Openshaw P.J. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection. J. Immunol. 161 (1998) 6215-6222
20. Kim H.W., Canchola J.G., Brandt C.D., Pyles G., Chanock R.M., Jensen K., and Parrott R.H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89 (1969) 422-434
21. Lenzo J.C., Mansfield J.P., Sivamoorthy S., Cull V.S., and James C.M. Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-alpha therapy. Cell. Immunol. 223 (2003) 77-86
22. Moser J.M., Gibbs J., Jensen P.E., and Lukacher A.E. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nat. Immunol. 3 (2002) 189-195
23. Nicholas J.A., Rubino K.L., Levely M.E., Adams E.G., and Collins P.L. Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins. J. Virol. 64 (1990) 4232-4241
24. Ostler T., and Ehl S. Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity. Eur. J. Immunol. 32 (2002) 2562-2569
25. Parker K.C., Bednarek M.A., and Coligan J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152 (1994) 163-175
26. Preston F.M., Beier P.L., and Pope J.H. Identification of the respiratory syncytial virus-induced immunosuppressive factor produced by human peripheral blood mononuclear cells in vitro as interferon-alpha. J. Infect. Dis. 172 (1995) 919-926
27. Prince G.A., Horswood R.L., Berndt J., Suffin S.C., and Chanock R.M. Respiratory syncytial virus infection in inbred mice. Infect. Immun. 26 (1979) 764-766
28. Rammensee H., Bachmann J., Emmerich N.P., Bachor O.A., and Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50 (1999) 213-219
29. + cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus. Virology 337 (2005) 335-343
30. Sacks D., and Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev., Immunol. 2 (2002) 845-858
31. Salkind A.R., McCarthy D.O., Nichols J.E., Domurat F.M., Walsh E.E., and Roberts Jr. N.J. Interleukin-1-inhibitor activity induced by respiratory syncytial virus: abrogation of virus-specific and alternate human lymphocyte proliferative responses. J. Infect. Dis. 163 (1991) 71-77
32. Schlender J., Walliser G., Fricke J., and Conzelmann K.K. Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact. J. Virol. 76 (2002) 1163-1170
33. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med. 186 (1997) 421-432
34. Stark J.M., McDowell S.A., Koenigsknecht V., Prows D.R., Leikauf J.E., Le Vine A.M., and Leikauf G.D. Genetic susceptibility to respiratory syncytial virus infection in inbred mice. J. Med. Virol. 67 (2002) 92-100
35. van Bleek G.M., Poelen M.C., van der M.R., Brugghe H.F., Timmermans H.A., Boog C.J., Hoogerhout P., Otten H.G., and van Els C.A. Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells. J. Virol. 77 (2003) 980-988
36. Waris M.E., Tsou C., Erdman D.D., Zaki S.R., and Anderson L.J. Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J. Virol. 70 (1996) 2852-2860